Afatinib (BIBW2992)

Catalog No.S1011

Afatinib (BIBW2992) Chemical Structure

Molecular Weight(MW): 485.94

Afatinib (BIBW2992) inhibits EGFR/ErbB irreversibly in vitro with IC50 of 0.5, 0.4, 10, 14, 1 nM for EGFRwt, EGFR L858R , EGFR L858R/T790M ErbB2 (HER2) and ErbB4 (HER4), respectively.

Size Price Stock Quantity  
In DMSO USD 240 In stock
USD 120 In stock
USD 210 In stock
USD 570 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 37 Publications

4 Customer Reviews

  • Cytoxicity of irreversible EGFR TKIS and ethacrynic acid on breast cells lines. A, Mean IC50 value of Afatinib.

    Oncotarget, 2016, 7(36):58038-58050. Afatinib (BIBW2992) purchased from Selleck.

    Inhibition of signaling pathway activation in lung tumor cell lines by kinase inhibitors. Lung tumor cells were cultured in 10% FBS until reaching ∼80% confluence and then the cells were starved in serum-free medium for overnight, followed by 4-hour treatment with the inhibitors. Cell lysates were then prepared and used for determination of the pathway activation signals by the CEER assay.

    Int J Proteomics 2011 2011, 215496. Afatinib (BIBW2992) purchased from Selleck.

  • Inhibition of anchorage-independent growth of lung tumor cell lines by selected inhibitors. Each selected cell line was treated with the indicated inhibitor at 0.1 μM and 1 μM concentrations for two weeks and cell colony size formation was scored under the Nikon inverted-phase microscope.

    Int J Proteomics 2011 2011, 215496. Afatinib (BIBW2992) purchased from Selleck.

    After starved in serum-free medium for 24h, Breast cancer cells incubated with the indicated concentrations of BIBW2992 for 3h,followed by 15-minute stimolation of 100ng/ml EGF

    Dr. Zhang of Tianjin Medical University. Afatinib (BIBW2992) purchased from Selleck.

Purity & Quality Control

Choose Selective EGFR Inhibitors

Biological Activity

Description Afatinib (BIBW2992) inhibits EGFR/ErbB irreversibly in vitro with IC50 of 0.5, 0.4, 10, 14, 1 nM for EGFRwt, EGFR L858R , EGFR L858R/T790M ErbB2 (HER2) and ErbB4 (HER4), respectively.
Targets
EGFR (L858R) [1]
(Cell-free assay)
EGFR (wt) [1]
(Cell-free assay)
ErbB4 [2]
(Cell-free assay)
EGFR (L858R/T790M) [1]
(Cell-free assay)
HER2 [1]
(Cell-free assay)
0.4 nM 0.5 nM 1 nM 10 nM 14 nM
In vitro

BIBW2992 shows potent activity against both wild-type and mutant forms of EGFR and HER2. It is similar to Gefitinib in potency against L858R EGFR, but about 100-fold more active against the Gefitinib resistant L858R-T790M EGFR double mutant. BIBW2992 exhibits potent effects on both EGFR and HER2 phosphorylation in vivo. It compares favorably to reference compounds (such as Lapatinib et al.) in all cell types tested, such as human epidermoid carcinoma cell line A431 expressing wt EGFR, murine NIH-3T3 cells transfected with wt HER2, as well as breast cancer cell line BT-474 and gastric cancer cell line NCI-N87, which express endogenous HER2. [1]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HDLM-2 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWfJZVlQUUN3ME2wMlAxPTd{IN88US=> M3H5SXNCVkeHUh?=
KASUMI-1 MoO2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml;NTWM2OD1yLkCwPVEyKM7:TR?= Ml7wV2FPT0WU
HCC2218 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF\2XnRKSzVyPUCuNFA6QDdizszN NWHkOog4W0GQR1XS
KARPAS-45 NXfnPGxET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFuw[41KSzVyPUCuNFE3PzFizszN MXfTRW5ITVJ?
HSC-4 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVf3XWkzUUN3ME2wMlAyPzR6IN88US=> NYD6SmtIW0GQR1XS
CHL-1 NXrwNZBST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1PJSGlEPTB;MD6wNVg{QSEQvF2= MXPTRW5ITVJ?
KY821 Mle3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWLJR|UxRTBwMEKwOkDPxE1? MkjSV2FPT0WU
NCI-N87 NVuwU5hIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYTBfHl3UUN3ME2wMlAzPzd|IN88US=> M2\q[HNCVkeHUh?=
DOK NEWzdm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV;Fc21lUUN3ME2wMlA{OTl2IN88US=> MWnTRW5ITVJ?
DSH1 MkGwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHe5cZhKSzVyPUCuNFM{OTRizszN NGfWdJpUSU6JRWK=
MDA-MB-175-VII NUfOV2FNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4DPNWlEPTB;MD6wN|QyPiEQvF2= MWjTRW5ITVJ?
NCI-H2170 M{TNOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmO1TWM2OD1yLkCzO|I5KM7:TR?= Mo\lV2FPT0WU
BT-474 M3fzUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV\JR|UxRTBwMES5PFYh|ryP NH;IboRUSU6JRWK=
EFO-27 NVz4eHNsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoLJTWM2OD1yLkC1NVgzKM7:TR?= M2XJZ3NCVkeHUh?=
NCI-H720 M4K2[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXy1R|JFUUN3ME2wMlA2OzJ3IN88US=> Ml\EV2FPT0WU
PC-14 M1SzSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFntN3dKSzVyPUCuNFU3PjhizszN M4O0VHNCVkeHUh?=
EC-GI-10 MnT6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHn5WXJKSzVyPUCuNFU6OTJizszN NFLENplUSU6JRWK=
KYSE-450 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1\xbGlEPTB;MD6wOVk4QCEQvF2= MYfTRW5ITVJ?
BPH-1 NXTCdmRoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlS5TWM2OD1yLkC1PVg5KM7:TR?= NGf5PHFUSU6JRWK=
NCI-H292 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF;v[2xKSzVyPUCuNFYxQSEQvF2= NEnUTJNUSU6JRWK=
H9 M3z3cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXHJR|UxRTBwMEexN|Ih|ryP MoC2V2FPT0WU
NCI-H526 M13j[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIHLOVdKSzVyPUCuNFc5OjNizszN NUn3bVZbW0GQR1XS
NCI-H1623 NVLte5hzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NU\mW2JvUUN3ME2wMlA5ODJ3IN88US=> MUXTRW5ITVJ?
KYSE-140 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3vpOGlEPTB;MD6wPFM{KM7:TR?= MmXFV2FPT0WU
Ca9-22 NUTTOHd1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUXJR|UxRTBwMEizOVMh|ryP NVXxb4tsW0GQR1XS
AU565 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXjJR|UxRTBwMEi1NFQh|ryP MVnTRW5ITVJ?
ZR-75-30 NUOwdohrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYDtdGR[UUN3ME2wMlA6PTR3IN88US=> MXPTRW5ITVJ?
NCI-H1770 MlmzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGTSNVlKSzVyPUCuNVAzQCEQvF2= NHf1N|FUSU6JRWK=
LB2241-RCC MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NInZOGxKSzVyPUCuNVA5QDRizszN MmXVV2FPT0WU
CAL-39 NFP4RXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnfGTWM2OD1yLkGxO|kzKM7:TR?= MkPVV2FPT0WU
UACC-893 NWniSGpOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXf6W4k{UUN3ME2wMlEyQDh3IN88US=> M4PpOXNCVkeHUh?=
LU-65 NF;WfWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVrJR|UxRTBwMUK2N|Mh|ryP MVrTRW5ITVJ?
HN MmK0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIWycnJKSzVyPUCuNVMxPzdizszN Mlm4V2FPT0WU
TI-73 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1;zbGlEPTB;MD6xOFcyPSEQvF2= M{ToW3NCVkeHUh?=
KU812 NVn4fHhJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1\aTmlEPTB;MD6xOVQ2PiEQvF2= M{nkWnNCVkeHUh?=
SW13 MlHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF7sUlVKSzVyPUCuNVYzOTZizszN MYHTRW5ITVJ?
BB30-HNC MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXX3fHFXUUN3ME2wMlE3PTd4IN88US=> NILDcZlUSU6JRWK=
HSC-2 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUTKbWtrUUN3ME2wMlE3QDN5IN88US=> M2PFbXNCVkeHUh?=
BV-173 NHzwN2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX;JR|UxRTBwMUe1PVYh|ryP MXnTRW5ITVJ?
CAL-27 NIHLWItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWPJR|UxRTBwMUe2N|Yh|ryP MoezV2FPT0WU
SBC-1 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4e1fmlEPTB;MD6xPFk2QSEQvF2= MYjTRW5ITVJ?
CAL-33 MoKwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1HDPWlEPTB;MD6yNFE5PCEQvF2= MlrDV2FPT0WU
NCI-H209 Mlj4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVe3Z2U1UUN3ME2wMlIxPDZizszN M2rvb3NCVkeHUh?=
COR-L105 MlvuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2jHUWlEPTB;MD6yNVA5PCEQvF2= NI\Pb5BUSU6JRWK=
HSC-3 Mn\GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGDnSHFKSzVyPUCuNlEyQThizszN M1e0enNCVkeHUh?=
NCI-H69 NIi0c3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUXJR|UxRTBwMkG0OVEh|ryP MonuV2FPT0WU
MOLT-13 M1PSTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M322cWlEPTB;MD6yN|k4PSEQvF2= NIm4T5lUSU6JRWK=
ML-2 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVTJR|UxRTBwMkS4NFIh|ryP NUjhRnhPW0GQR1XS
IGROV-1 NIqxTG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIi3d|ZKSzVyPUCuNlU6PTJizszN Mo\SV2FPT0WU
TK10 NGKwXHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF\IOotKSzVyPUCuNlY4OzhizszN M2X4e3NCVkeHUh?=
EoL-1-cell MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3zFS2lEPTB;MD6yOlg6OiEQvF2= M2fzVXNCVkeHUh?=
HO-1-N-1 NVnmPVVYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M17PO2lEPTB;MD6yO|g2OyEQvF2= NF;hdppUSU6JRWK=
BHY MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1fmbmlEPTB;MD6yPFY2PSEQvF2= M3\EOnNCVkeHUh?=
LU-139 NHeyO5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml;oTWM2OD1yLkOwOVEh|ryP M1jQd3NCVkeHUh?=
23132-87 M4LjOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXjJR|UxRTBwM{G5NlMh|ryP NIG0UYJUSU6JRWK=
ACHN MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkLQTWM2OD1yLkOxPVk1KM7:TR?= NIHJSVJUSU6JRWK=
DoTc2-4510 NF;LUWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NI\PO4dKSzVyPUCuN|IzOTlizszN MVrTRW5ITVJ?
BB65-RCC M1mzc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHziOJRKSzVyPUCuN|Q2QTNizszN MWjTRW5ITVJ?
HLE MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWXJR|UxRTBwM{WwOFYh|ryP MVHTRW5ITVJ?
HCC1419 M4TCbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGPPd5RKSzVyPUCuN|Y1ODhizszN MXfTRW5ITVJ?
A388 MmPqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWLJR|UxRTBwM{[4OVch|ryP NGrtXolUSU6JRWK=
NUGC-3 NGr4NlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3LTN2lEPTB;MD6zPFM4OyEQvF2= MnzoV2FPT0WU
KYSE-180 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M363[GlEPTB;MD6zPVA5QSEQvF2= MXfTRW5ITVJ?
TE-6 NW\KenZzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIi3TFVKSzVyPUCuOFAzPDZizszN NH3TeWZUSU6JRWK=
A498 NH\3[3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnnTTWM2OD1yLkSwOlc1KM7:TR?= NWrYRY5EW0GQR1XS
NCI-H1648 NIHFflBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUjJR|UxRTBwNESxPFIh|ryP MWXTRW5ITVJ?
DU-145 MmDwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmeyTWM2OD1yLkS0PFM{KM7:TR?= MYHTRW5ITVJ?
CW-2 NWPWZ2JST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXnJR|UxRTBwNE[5NVQh|ryP NYPF[GpjW0GQR1XS
A431 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2TnZmlEPTB;MD60PFI{OyEQvF2= Ml;TV2FPT0WU
SAS MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUnJR|UxRTBwNEizPVgh|ryP NUDKR45xW0GQR1XS
NCI-H2126 M1PEWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmGwTWM2OD1yLkWxPVI3KM7:TR?= NULlXXJbW0GQR1XS
NCI-H358 NEPSSYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHniUm1KSzVyPUCuOVMzOSEQvF2= NXzR[WI5W0GQR1XS
FADU NE\JXXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4raNWlEPTB;MD61OFQxPCEQvF2= MWjTRW5ITVJ?
ACN NGPPTVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX7JR|UxRTBwNUWwPVQh|ryP NYTOb5hFW0GQR1XS
HCC70 MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnXSTWM2OD1yLkW3OlYyKM7:TR?= M3nRTHNCVkeHUh?=
NCI-H1838 NGWw[ZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXHHVXhWUUN3ME2wMlYxOjl7IN88US=> M2[3UnNCVkeHUh?=
CAL-54 M1e4XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mo\OTWM2OD1yLk[xOlIyKM7:TR?= NUTYdHVqW0GQR1XS
NCI-H1975 M3qzbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4K1bGlEPTB;MD62NVczQCEQvF2= M2HpO3NCVkeHUh?=
COR-L88 MkT6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NW\sZVRQUUN3ME2wMlY1OTF|IN88US=> NXm4XJJpW0GQR1XS
CTV-1 NYTVe5J7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4PNR2lEPTB;MD62OFM6OiEQvF2= Ml7NV2FPT0WU
EW-18 NX7uenpDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX3wbmdtUUN3ME2wMlY5Pjl6IN88US=> NFPDXHlUSU6JRWK=
HCC1806 NIn0fYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYrTN|FPUUN3ME2wMlY6PjZ4IN88US=> NEPvXmlUSU6JRWK=
HuP-T4 M2ntN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVvIS2VNUUN3ME2wMlY6PzZizszN M3v4NHNCVkeHUh?=
MDA-MB-361 MnG5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXiyfWdUUUN3ME2wMlczPjZ{IN88US=> NWjaOGQyW0GQR1XS
NCI-H1573 MmXzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2O5VWlEPTB;MD63N|Y{KM7:TR?= M172O3NCVkeHUh?=
KU-19-19 NYHWc5pmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkXiTWM2OD1yLke3OFY1KM7:TR?= MWjTRW5ITVJ?
COLO-678 M4W1Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NU\aRox7UUN3ME2wMlgxQDN2IN88US=> NYLGT|E2W0GQR1XS
C-33-A NXXVSI4{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVvJR|UxRTBwOEGyPVch|ryP MWTTRW5ITVJ?
Calu-3 NEn4U21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUP2SoMyUUN3ME2wMlgyPDN2IN88US=> M3HsPHNCVkeHUh?=
AGS MkHLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXzJR|UxRTBwOEO2OFgh|ryP NXLhbXc5W0GQR1XS
SCC-25 NYKxe3dqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGnEPWlKSzVyPUCuPFQyPzFizszN M3S2Z3NCVkeHUh?=
JVM-2 M1HLRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIO1ZZBKSzVyPUCuPFgzQTlizszN MXTTRW5ITVJ?
HCE-T NH\ENVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX;JR|UxRTBwOEi0Nlgh|ryP NYfHNXlCW0GQR1XS
ES4 Mnq0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXjpb|M5UUN3ME2wMlk4QDN4IN88US=> MYXTRW5ITVJ?
EKVX MljwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXzJR|UxRTFwMEGwOlQh|ryP MnviV2FPT0WU
D-542MG M1juPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGjzWJhKSzVyPUGuNFExPjRizszN Mn\NV2FPT0WU
SW1116 M2S1Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3TpN2lEPTB;MT6wNVI5PyEQvF2= NELkO3lUSU6JRWK=
5637 Mly0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWLuNopSUUN3ME2xMlAyPTFizszN M4HTXXNCVkeHUh?=
HT-1376 Ml\NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmPnTWM2OD1zLkCxOVE{KM7:TR?= NUnSN45WW0GQR1XS
NB69 MnX6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmrwTWM2OD1zLkCyPVQ2KM7:TR?= MkPRV2FPT0WU
YKG-1 NV7US2dPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWqxUYlGUUN3ME2xMlA2PDF7IN88US=> NVPGW|RZW0GQR1XS
EW-3 NH;qXpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFHmZ49KSzVyPUGuNFc5QDNizszN NFr0eWZUSU6JRWK=
GCIY Ml7MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NI[xRZZKSzVyPUGuNFgyODRizszN M4nwe3NCVkeHUh?=
SK-MES-1 NX[zZpJuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1jtT2lEPTB;MT6xNVQ5PyEQvF2= MkS4V2FPT0WU
PANC-08-13 NVP3cGVzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoHvTWM2OD1zLkG2OFE3KM7:TR?= NXvmUpBVW0GQR1XS
SK-NEP-1 NYDa[VlDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MljLTWM2OD1zLkG3OVE{KM7:TR?= MXPTRW5ITVJ?
SW954 M2DVemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWLOcYZrUUN3ME2xMlIxOjF2IN88US=> M2XCc3NCVkeHUh?=
NCI-SNU-5 NX;MPJl7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnmyTWM2OD1zLkKzPUDPxE1? MYnTRW5ITVJ?
SW48 NYi3N2x3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUTJR|UxRTFwMkW0N|Ih|ryP NUHIbVNFW0GQR1XS
HT-3 NX7TWZcxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXzJR|UxRTFwMki3OVMh|ryP NV23dpVPW0GQR1XS
ETK-1 M1;4dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoPnTWM2OD1zLkO3OFU3KM7:TR?= MmLiV2FPT0WU
SCC-15 NEO5eYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoKzTWM2OD1zLkO5OFUyKM7:TR?= NIXleXJUSU6JRWK=
DU-4475 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVHJR|UxRTFwNECxNlEh|ryP MWLTRW5ITVJ?
NB5 NYW1ToNRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml;JTWM2OD1zLkSxN|E4KM7:TR?= NW\QZlhoW0GQR1XS
CFPAC-1 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIPWeVlKSzVyPUGuOFI1QTNizszN MlPXV2FPT0WU
NCI-H630 NUHHNm54T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkTwTWM2OD1zLkS1OVgzKM7:TR?= NX3rRo1pW0GQR1XS
NCI-H82 M4PkdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmLVTWM2OD1zLkW0NFA3KM7:TR?= NW\SZ2xCW0GQR1XS
ECC10 M2S3WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkHNTWM2OD1zLkW1N|Y6KM7:TR?= M{Sxc3NCVkeHUh?=
K5 NIHoW5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnqxTWM2OD1zLkW4N|U4KM7:TR?= NUfKXos1W0GQR1XS
ME-180 NFHhcItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYD0bVVJUUN3ME2xMlYyODl4IN88US=> NXPMdZkxW0GQR1XS
KYSE-410 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX\TTXBbUUN3ME2xMlY2Pjd{IN88US=> M{TKcHNCVkeHUh?=
G-401 NFTu[5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV\JR|UxRTFwNke0NVMh|ryP NGHXTIlUSU6JRWK=
TGBC24TKB MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NE\hdI5KSzVyPUGuOlgzOyEQvF2= NUTlbIRFW0GQR1XS
Detroit562 NFLWOIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVrJR|UxRTFwN{CxOVIh|ryP NI\I[mNUSU6JRWK=
OE19 MmrVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFHsVmVKSzVyPUGuO|E2OTJizszN M3KwenNCVkeHUh?=
CAKI-1 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXnJR|UxRTFwN{iyNVEh|ryP NWLiXHpoW0GQR1XS
TE-12 M3jUfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEniOllKSzVyPUGuPFA1OTRizszN NGTZOppUSU6JRWK=
NCI-H1666 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{L1[GlEPTB;MT64NFk1QCEQvF2= MoTwV2FPT0WU
TE-1 MkC5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MY\JR|UxRTFwOEG0O|Uh|ryP M2H2bHNCVkeHUh?=
CAL-12T M2\0TGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3jZN2lEPTB;MT64PFk1PSEQvF2= NV;VR21zW0GQR1XS
TE-8 NYn0dZZlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoT2TWM2OD1zLkmxN|c4KM7:TR?= NGDmZolUSU6JRWK=
KYSE-270 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NED4SFRKSzVyPUKuNFI4OzJizszN MUjTRW5ITVJ?
GMS-10 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2WyXWlEPTB;Mj6wN|UyPyEQvF2= NWHBVFNbW0GQR1XS
A2780 MoTkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHnKU2RKSzVyPUKuNFYzQTRizszN NHzZdIRUSU6JRWK=
OMC-1 MkXES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1XYd2lEPTB;Mj6wPFE3QSEQvF2= M3G0OHNCVkeHUh?=
LoVo Moj0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3HEb2lEPTB;Mj6xNFc6PyEQvF2= Ml\5V2FPT0WU
PANC-03-27 Ml7GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH:w[mNKSzVyPUKuNVY3OzFizszN MXPTRW5ITVJ?
MDA-MB-157 M4nCPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1vremlEPTB;Mj6yNVgzQCEQvF2= MXHTRW5ITVJ?
CaR-1 MmHuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MY\JR|UxRTJwMkiyPFEh|ryP M3W3XHNCVkeHUh?=
769-P MlfBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYXJR|UxRTJwMkmwN|ch|ryP NFP4VWtUSU6JRWK=
NB7 M4K1fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHnSc|FKSzVyPUKuNlk3PzZizszN NYDOO5NmW0GQR1XS
MKN7 M{Hvcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV\JR|UxRTJwM{WzN|Uh|ryP MV7TRW5ITVJ?
NCI-H1048 NF3pfWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2T4[mlEPTB;Mj60PVE2QCEQvF2= NUPZ[FlwW0GQR1XS
RCM-1 NXnyUlZsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnToTWM2OD1{LkWyPVM5KM7:TR?= NHvYdI5USU6JRWK=
HT55 NH;QOnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NI[0b3pKSzVyPUKuOVc{QCEQvF2= MoXwV2FPT0WU
HCC1569 MoDYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1vOOmlEPTB;Mj61PFI6PyEQvF2= MmTTV2FPT0WU
LXF-289 NWTSTG9RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWPJR|UxRTJwNkO1OlUh|ryP M3z1dnNCVkeHUh?=
OVCAR-3 NU[x[VNRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoDyTWM2OD1{Lk[3NVY4KM7:TR?= MVvTRW5ITVJ?
TE-10 Mo[4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnvWTWM2OD1{Lk[4NFc5KM7:TR?= NUnFeo5RW0GQR1XS
SNU-C2B NYfVRWFWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYXFZmxIUUN3ME2yMlY5PjF4IN88US=> NF75[|JUSU6JRWK=
LB1047-RCC Mn\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXLJR|UxRTJwN{S4PFgh|ryP NFzTdJNUSU6JRWK=
SN12C Mn;DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4D2XWlEPTB;Mj65NVk3PCEQvF2= M1fZbHNCVkeHUh?=
786-0 M2PoUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIfpXXZKSzVyPUOuNFY1ODhizszN M{nBXHNCVkeHUh?=
HT-29 M17pWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXvuN3NSUUN3ME2zMlA4OzB7IN88US=> NGD1S3RUSU6JRWK=
RPMI-7951 MnvTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV6yO|FtUUN3ME2zMlA4PTlizszN M1jkbXNCVkeHUh?=
NBsusSR NVrqbI9RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVzkc2F3UUN3ME2zMlE5OjV2IN88US=> NWXEcIlZW0GQR1XS
NKM-1 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkCzTWM2OD1|LkG4O|Q1KM7:TR?= NVHNV5Q{W0GQR1XS
Capan-2 M{jGWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3HoO2lEPTB;Mz60Olg4PSEQvF2= MUfTRW5ITVJ?
MKN1 M1zJTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGHhZ4tKSzVyPUOuOFcyODhizszN M1nscnNCVkeHUh?=
OAW-42 NWnj[5ZIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVPJR|UxRTNwNUCwNlYh|ryP M1e3W3NCVkeHUh?=
SKG-IIIa NGjMb2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlrxTWM2OD1|LkWyNlM4KM7:TR?= MYrTRW5ITVJ?
no-11 MmDLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXvqNIFoUUN3ME2zMlU{PTZ2IN88US=> NIrYcVNUSU6JRWK=
NY NGLpdmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXzJR|UxRTNwNUO2OVUh|ryP MVHTRW5ITVJ?
HEC-1 Mm\tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIXnem5KSzVyPUOuOVg6PSEQvF2= NFvqZ3dUSU6JRWK=
NCI-H441 NHX0bJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYLJR|UxRTNwNUm4OFEh|ryP M3XLSXNCVkeHUh?=
NCI-H2009 MknTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M375TWlEPTB;Mz62NVIyPiEQvF2= MlPRV2FPT0WU
T47D MoTpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4LSbGlEPTB;Mz62NlIyPyEQvF2= Mli0V2FPT0WU
SNU-449 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnnlTWM2OD1|Lk[1PFI3KM7:TR?= NYDYeVVEW0GQR1XS
NCI-SNU-1 MoOwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFXNd4VKSzVyPUOuOlk4OzVizszN NWe5ZXZ1W0GQR1XS
BT-20 NVi1Wm9oT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVj3epA2UUN3ME2zMlY6Pzl3IN88US=> M2q1OHNCVkeHUh?=
LS-123 NHLPcHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3n1XGlEPTB;Mz63OFI5PCEQvF2= NGjXcWFUSU6JRWK=
8305C MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWDZXm51UUN3ME2zMlc2QTFzIN88US=> NHv4Z5dUSU6JRWK=
OCUB-M MoPMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYTJR|UxRTNwN{[xPFch|ryP MV\TRW5ITVJ?
KOSC-2 NH\2b2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MW\JR|UxRTNwOEO0OVEh|ryP NITQeIZUSU6JRWK=
NCI-H1693 M2rWUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV3QVpBPUUN3ME2zMlg1OThzIN88US=> MonQV2FPT0WU
TE-9 M1TnN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NG\CcG1KSzVyPUOuPFQ{QDJizszN MULTRW5ITVJ?
MV-4-11 NUfIcXFIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGKzNm1KSzVyPUOuPFc6QTRizszN Ml;UV2FPT0WU
GAMG MlLkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGjyO2VKSzVyPUOuPVE{OTRizszN NFy1VWxUSU6JRWK=
KNS-62 NHHwS5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlLMTWM2OD1|Lkm0O|MyKM7:TR?= MXrTRW5ITVJ?
MC116 M4LIbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF70PHBKSzVyPUOuPVU1QDlizszN NFLYVmFUSU6JRWK=
647-V MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYjJR|UxRTNwOUi0OVIh|ryP NEXneYlUSU6JRWK=
U-87-MG M4Ppb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUPJR|UxRTRwMUC0PFEh|ryP NEflVnZUSU6JRWK=
RPMI-8226 MlzES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3fPR2lEPTB;ND6xNVY{OSEQvF2= NWjSVWdJW0GQR1XS
SW1417 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWLWbYV{UUN3ME20MlEzOTR5IN88US=> MYPTRW5ITVJ?
LAMA-84 NWHsNWZRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUfvNmp{UUN3ME20MlE4ODJizszN MVPTRW5ITVJ?
LS-513 NHfKdpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3ez[GlEPTB;ND6zNVIyPyEQvF2= NGLmU3pUSU6JRWK=
KLE NXXOc2ZKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MknyTWM2OD12LkSwPFE6KM7:TR?= MYDTRW5ITVJ?
HCT-116 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXO2WlNpUUN3ME20MlQyODB5IN88US=> NWTVWHN6W0GQR1XS
EPLC-272H NWrCVGRRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M37KemlEPTB;ND60NVU{OyEQvF2= MVPTRW5ITVJ?
KS-1 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXrjSpJHUUN3ME20MlUxQDh7IN88US=> NWjVSHR7W0GQR1XS
HT-1197 MmH2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M13Od2lEPTB;ND61NlY3QSEQvF2= NXjtS3Q5W0GQR1XS
LCLC-97TM1 MorUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoXpTWM2OD12LkWzOlg3KM7:TR?= NVjOUZhkW0GQR1XS
ES5 NX;3[5lyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV7JR|UxRTRwOEO3NlMh|ryP MX3TRW5ITVJ?
CTB-1 Mnv3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUf2TlN1UUN3ME20Mlg1QDhizszN MkPTV2FPT0WU
HL-60 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYKxfmVvUUN3ME20Mlg3PjFzIN88US=> M1fS[3NCVkeHUh?=
VM-CUB-1 MlLFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXrJR|UxRTRwOE[4NVkh|ryP M{HOfXNCVkeHUh?=
MEG-01 M1S3S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoHHTWM2OD12Lkm5OFA{KM7:TR?= M2n5dXNCVkeHUh?=
KYSE-520 NUXmcoFCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVXJR|UxRTVwMkC4N|kh|ryP NXy0eJVTW0GQR1XS
HuO-3N1 NEPVPYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnXsTWM2OD13LkK0NFQ{KM7:TR?= MYPTRW5ITVJ?
SW620 M2S2VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUHPWpFmUUN3ME21MlI1QTZ2IN88US=> NHvBU3BUSU6JRWK=
U031 MnO0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWDJR|UxRTVwMkW0NlQh|ryP MkfVV2FPT0WU
TE-5 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVjJR|UxRTVwNEC4OUDPxE1? NITsSGRUSU6JRWK=
NCI-H747 Mny2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYrJR|UxRTVwNEK0O|Ih|ryP NHHjXmdUSU6JRWK=
MG-63 MlTYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4rpSWlEPTB;NT60PFc3OiEQvF2= MUDTRW5ITVJ?
HC-1 M{fG[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWe0Npl1UUN3ME21MlUyQDN7IN88US=> NUfPZ49pW0GQR1XS
HCC2998 M4HvS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1z6eWlEPTB;NT61NlYyPSEQvF2= M1rRfnNCVkeHUh?=
NTERA-S-cl-D1 NX\vbFVwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUDIem1qUUN3ME21MlU1PTN5IN88US=> MX\TRW5ITVJ?
KINGS-1 M2r1W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2HPeWlEPTB;NT62NFk1PCEQvF2= MnT2V2FPT0WU
D-423MG NY[2cHhXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4X0UmlEPTB;NT62NVcxPSEQvF2= MlG0V2FPT0WU
SW962 NYPablFiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGfwemlKSzVyPUWuOlIxOzJizszN NHy2Z3ZUSU6JRWK=
LOXIMVI NIXmc2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mlf3TWM2OD13Lk[zPFc{KM7:TR?= NELm[YdUSU6JRWK=
LS-411N NWHFeZdyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NI\xRWNKSzVyPUWuO|k1PDFizszN Mlu1V2FPT0WU
NCI-H2291 NHfkNo1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX7GOZA4UUN3ME21Mlk5QTR|IN88US=> M4PJZnNCVkeHUh?=
A549 NFzCSWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTZwMUK1OVMh|ryP NYnZdoZSW0GQR1XS
LS-1034 M2jUNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIruZohKSzVyPU[uNlA4ODZizszN M3TFTnNCVkeHUh?=
NB14 NI\LUnVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEjvW3BKSzVyPU[uOFM5OzZizszN MWPTRW5ITVJ?
NCI-H1299 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXnJR|UxRTZwNkOxO|Eh|ryP MnnzV2FPT0WU
BT-549 M13WfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mli3TWM2OD14Lk[2PFg6KM7:TR?= M3vTR3NCVkeHUh?=
J-RT3-T3-5 M4CwV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYPTco5YUUN3ME22Mlg3QSEQvF2= M2HnPHNCVkeHUh?=
SW756 NFfK[GtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlnRTWM2OD14LkmxNVc3KM7:TR?= M2jad3NCVkeHUh?=
DJM-1 NXvpNpduT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4LLXmlEPTB;Nj65NlAyOiEQvF2= Mlr5V2FPT0WU
GP5d NH[y[HdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYnlcWZMUUN3ME22Mlk4Ozl2IN88US=> MYHTRW5ITVJ?
MOLT-4 MlyyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGLKO5dKSzVyPUeuNFIyOzVizszN Mn34V2FPT0WU
NCI-H28 MlrxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{jqb2lEPTB;Nz6xOlQxPSEQvF2= MVvTRW5ITVJ?
MN-60 MoTpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUjJR|UxRTdwMkiwPFkh|ryP NWjrUIx6W0GQR1XS
RMG-I NWTvXIYyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUjJR|UxRTdwM{myPVYh|ryP MnTBV2FPT0WU
COLO-800 MlTRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4O4U2lEPTB;Nz60NVQ1PiEQvF2= NIr6[pNUSU6JRWK=
DB NFnnXIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXr3NFdSUUN3ME23MlYyODB3IN88US=> MnHuV2FPT0WU
Ca-Ski M1;adWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2fhOWlEPTB;Nz62OFI2QSEQvF2= M3HNNnNCVkeHUh?=
HEL M{LLT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUHUU|NSUUN3ME23MlcyOjB|IN88US=> NHfROlRUSU6JRWK=
NH-12 NVrrflRST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmnaTWM2OD15LkeyPFA5KM7:TR?= NFXEfnRUSU6JRWK=
LB373-MEL-D NUH6UHI4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4q0[2lEPTB;Nz63Olc4OSEQvF2= NYL4T5hFW0GQR1XS
SW900 MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUfJR|UxRTdwOEKxNlEh|ryP M3G2PXNCVkeHUh?=
JVM-3 NEnKVWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1LJdmlEPTB;Nz64PVU6QSEQvF2= MlniV2FPT0WU
OAW-28 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4rDUGlEPTB;Nz65OFU4QCEQvF2= MX;TRW5ITVJ?
KURAMOCHI NWOwPGc{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml3FTWM2OD15Lkm0PFEyKM7:TR?= MUfTRW5ITVJ?
BE-13 MnGyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVvCU5BNUUN3ME23Mlk5OTF{IN88US=> MmLkV2FPT0WU
VMRC-RCZ M2LQdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVTjOWdkUUN3ME24MlAyPjl5IN88US=> Mn\zV2FPT0WU
NCI-H727 M2T2OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MULJR|UxRThwMUC0NkDPxE1? MYnTRW5ITVJ?
SW1710 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYHJR|UxRThwMUi1NVUh|ryP Ml;TV2FPT0WU
D-502MG MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MorwTWM2OD16LkK5NlgzKM7:TR?= MYrTRW5ITVJ?
NCI-H1993 MkfRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFXYfmFKSzVyPUiuN|M3OzFizszN MmLLV2FPT0WU
SCC-4 M1\LVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlPUTWM2OD16LkS0NFU6KM7:TR?= NEHvcmFUSU6JRWK=
HAL-01 NHjhTXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlqwTWM2OD16LkWxPVEh|ryP NXXVfHpQW0GQR1XS
GT3TKB M4S2dmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWrKPHQ5UUN3ME24MlY4QTZ2IN88US=> M3zOZnNCVkeHUh?=
SK-OV-3 NEnHNYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGGx[ohKSzVyPUiuO|E{OjlizszN NXWzTndDW0GQR1XS
COLO-829 NWXkUIFbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFLtPHJKSzVyPUiuPFA6PzZizszN NH;pWo5USU6JRWK=
OCI-AML2 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXqy[HFtUUN3ME24Mlk2PDhzIN88US=> NVzING9tW0GQR1XS
OS-RC-2 NXTKUpRNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkS3TWM2OD17LkCyNVkh|ryP MYTTRW5ITVJ?
BFTC-909 M1vHRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4nC[GlEPTB;OT6wOlc6QSEQvF2= MlXhV2FPT0WU
EW-11 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmP3TWM2OD17LkG3OlU{KM7:TR?= MVrTRW5ITVJ?
HCE-4 NH3wbGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWTJR|UxRTlwMkG1OVgh|ryP NHnofYhUSU6JRWK=
BALL-1 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXTJR|UxRTlwMkG5NFch|ryP NXfWToJ5W0GQR1XS
SF539 MkHMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFK1TIxKSzVyPUmuNlM2PjJizszN M2ntZnNCVkeHUh?=
CAMA-1 MoDJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH7MeFFKSzVyPUmuNlgyOjhizszN NVfw[mFlW0GQR1XS
C32 NGfhZWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHf0UnRKSzVyPUmuN|MxPjRizszN M3:1[HNCVkeHUh?=
NCI-H1703 NFrX[GhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{PUc2lEPTB;OT6zOFM4PSEQvF2= MXLTRW5ITVJ?
NCI-H1650 NHLyW3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGjSWJlKSzVyPUmuOlA6PDZizszN NWWwOHB[W0GQR1XS
NCI-H1563 MnTwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYDVNphOUUN3ME25Mlc3ODNzIN88US=> NGXNeIVUSU6JRWK=
CAL-85-1 M4fuWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4PoVWlEPTB;OT64O|M5OyEQvF2= MmDJV2FPT0WU
UM-UC-3 NFHTd5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVTT[mIyUUN3ME25Mlk2ODNizszN NXjP[I55W0GQR1XS
BxPC-3 NWnCWnM3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFvRV45KSzVyPUGwMlA6PzJizszN MVPTRW5ITVJ?
MHH-PREB-1 NYTQVlhCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkS4TWM2OD1zMD6xPVk6KM7:TR?= M1vXeXNCVkeHUh?=
DEL NIfLfHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWjJR|UxRTFyLkO5OFYh|ryP MV7TRW5ITVJ?
HuCCT1 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHz6fINKSzVyPUGwMlYxOzNizszN MkXYV2FPT0WU
OVCAR-4 MmXHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnHKTWM2OD1zMD64PFM2KM7:TR?= M4rY[nNCVkeHUh?=
CAL-72 M{jPeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mlr1TWM2OD1zMD65N|kyKM7:TR?= NH:zR3FUSU6JRWK=
HCC1954 NIey[3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXXiRVI5UUN3ME2xNU4xPzV2IN88US=> NVLTTY5oW0GQR1XS
EFO-21 NHvGSFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH7iVZdKSzVyPUGxMlExPDVizszN NEXaNXZUSU6JRWK=
FTC-133 NWnySGVZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkT0TWM2OD1zMT6xOFA4KM7:TR?= NYPDPW9vW0GQR1XS
SK-MEL-24 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVzZN|VwUUN3ME2xNU4zOzZ4IN88US=> NYC0cJhFW0GQR1XS
UACC-62 NUHjSW5RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHTJVlhKSzVyPUGxMlI{PjhizszN M4fqNHNCVkeHUh?=
NCI-H650 NXW0R4FXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV3JR|UxRTFzLkK0NVgh|ryP MWrTRW5ITVJ?
ALL-PO M13XTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3jmZWlEPTB;MUGuNlUyOiEQvF2= NYL4U2FuW0GQR1XS
T84 MoDYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIW0WYZKSzVyPUGxMlM6ODdizszN NYf2RlNYW0GQR1XS
IST-MEL1 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVLhfG1CUUN3ME2xNU41PTV7IN88US=> MXrTRW5ITVJ?
SW626 MlezS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVHJR|UxRTFzLkW3OVUh|ryP NHzJXIFUSU6JRWK=
RPMI-2650 NXfHWWs6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVjJR|UxRTFzLkW4PFUh|ryP NHXjb2ZUSU6JRWK=
MC-IXC NEPYZlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4LIZWlEPTB;MUGuOlczQCEQvF2= M136RXNCVkeHUh?=
HOP-62 NYq2eJp3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2fnO2lEPTB;MUGuOlc3PCEQvF2= NYDR[2JOW0GQR1XS
NOS-1 NHzhXIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUC4[4wzUUN3ME2xNU44OTB7IN88US=> Mm\1V2FPT0WU
SW1573 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUXJR|UxRTFzLkeyPVUh|ryP MVPTRW5ITVJ?
WM-115 M3jpPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYLyOop4UUN3ME2xNU44PTh6IN88US=> MlXkV2FPT0WU
HuO9 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGLNdplKSzVyPUGxMlg4PzRizszN MlXvV2FPT0WU
YAPC NF\KeYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWK3cY54UUN3ME2xNU46OjV7IN88US=> NXf2WmM2W0GQR1XS
MDA-MB-453 NI\5XXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXLTUopVUUN3ME2xNU46PTF3IN88US=> MULTRW5ITVJ?
NCI-H596 MoPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXfJR|UxRTF{LkCzOlkh|ryP NXTPZmVvW0GQR1XS
A172 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVrJR|UxRTF{LkC3PVgh|ryP M3zSZnNCVkeHUh?=
RS4-11 M3vMOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mm\sTWM2OD1zMj6xO|I2KM7:TR?= NXnRXlIyW0GQR1XS
HCC1937 NVe0N3hpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoLxTWM2OD1zMj63OVY1KM7:TR?= M4rl[XNCVkeHUh?=
SW837 M2n6bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWTJR|UxRTF{LkmwNlgh|ryP MVnTRW5ITVJ?
NMC-G1 NIPGeJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn\xTWM2OD1zMj65NlM1KM7:TR?= NGnuXXVUSU6JRWK=
PFSK-1 Mn7VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWTJR|UxRTF|LkC2JO69VQ>? NUG3TmlJW0GQR1XS
DBTRG-05MG M3u2eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHjFVnlKSzVyPUGzMlA3OzJizszN MX3TRW5ITVJ?
SK-UT-1 NGXWU|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWmwPXdNUUN3ME2xN{4yODh|IN88US=> NYLzXW1lW0GQR1XS
OVCAR-5 MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2P1b2lEPTB;MUOuNVU6OyEQvF2= M4HFdXNCVkeHUh?=
8505C M17uWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV;JR|UxRTF|LkKwOlch|ryP NHiyNmNUSU6JRWK=
SK-MEL-1 M2fmc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVPJR|UxRTF|LkexN|Uh|ryP NXXaSo5VW0GQR1XS
LK-2 NFfaV2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1T3dmlEPTB;MUOuO|Y{QSEQvF2= NXPoVWxqW0GQR1XS
OE33 MnzCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4D1bGlEPTB;MUOuO|g3KM7:TR?= M1zMc3NCVkeHUh?=
Ramos-2G6-4C10 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVfJR|UxRTF2LkCyNFIh|ryP MoTPV2FPT0WU
EW-13 Mnm2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHPmT4JKSzVyPUG0MlA{PTJizszN NHHYdlZUSU6JRWK=
NCI-H1793 NUDLS2FMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mnz5TWM2OD1zND6yNFg4KM7:TR?= MnX4V2FPT0WU
BHT-101 NIrEd|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4fVb2lEPTB;MUSuNlQyKM7:TR?= NHi0WXZUSU6JRWK=
RKO M4TGRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH\IOmtKSzVyPUG0MlUxPzVizszN M3fscHNCVkeHUh?=
NEC8 MnKwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmHyTWM2OD1zND61OFczKM7:TR?= NELDemJUSU6JRWK=
PANC-10-05 MlrIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEfDVVVKSzVyPUG0MlYzPDdizszN NFLLWoRUSU6JRWK=
NCI-H2030 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn6zTWM2OD1zND62OFQ5KM7:TR?= MXrTRW5ITVJ?
C2BBe1 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3S4PGlEPTB;MUSuO|Y1KM7:TR?= NWXqb|VYW0GQR1XS
EM-2 NX7Sd2lET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUDJR|UxRTF2Lki1O|Yh|ryP NFXPZ4pUSU6JRWK=
HCC1395 NYDC[254T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlfOTWM2OD1zND65N|M5KM7:TR?= NWqyenhLW0GQR1XS
A2058 NXzlNnZQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoXaTWM2OD1zNT6wOFA6KM7:TR?= M1\MTHNCVkeHUh?=
SW1463 NHXxSHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUTud3duUUN3ME2xOU4xPDh3IN88US=> MlzZV2FPT0WU
J82 NXnLWY5ZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV;Q[m1UUUN3ME2xOU4xPTdizszN MWjTRW5ITVJ?
CAL-120 NXflRot4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEHkOlFKSzVyPUG1MlE1PDdizszN M4G4OXNCVkeHUh?=
COLO-824 M{f3Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mmn1TWM2OD1zNT6xOVc6KM7:TR?= M2rSWXNCVkeHUh?=
LNCaP-Clone-FGC NGTUZphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVHpUmhYUUN3ME2xOU41OjR6IN88US=> NXHFUHdiW0GQR1XS
CP66-MEL M{LnTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGrEZolKSzVyPUG1MlQ3QDhizszN Mmn6V2FPT0WU
OC-314 NIjOeFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV7EdJVjUUN3ME2xOU41PzF2IN88US=> Mny3V2FPT0WU
OVCAR-8 MnyzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3nnTGlEPTB;MUWuPFg3OSEQvF2= M{nKeXNCVkeHUh?=
MFE-280 NELFZnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYrJR|UxRTF4LkC0PFgh|ryP NUH4NnR7W0GQR1XS
MHH-NB-11 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWntU|lbUUN3ME2xOk4xQDN7IN88US=> M3\RcHNCVkeHUh?=
SW1990 NXPwcmZjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHLyUoxKSzVyPUG2MlE4PTVizszN M3HSc3NCVkeHUh?=
U-266 Moj5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUnOUJN3UUN3ME2xOk4zOjl7IN88US=> MlnSV2FPT0WU
MFM-223 M365cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NE\IbVhKSzVyPUG2MlM6PjVizszN M4HVSnNCVkeHUh?=
L-363 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlXSTWM2OD1zNj60OVc4KM7:TR?= MWHTRW5ITVJ?
MCF7 Ml7IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX7JR|UxRTF4LkS3NlMh|ryP M4XsXXNCVkeHUh?=
SK-MEL-3 NVHmWVN5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXfJR|UxRTF4LkS3PFch|ryP MmL1V2FPT0WU
HH NYW3fYx[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIHzcodKSzVyPUG2MlUyPjJizszN Mo\FV2FPT0WU
no-10 MmDsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVXUTmRFUUN3ME2xOk43OzR|IN88US=> NWDTemlpW0GQR1XS
HuP-T3 NUflfnVET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYHJR|UxRTF4Lk[1O|Yh|ryP NGrKPXRUSU6JRWK=
QIMR-WIL MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkXYTWM2OD1zNj63NVA2KM7:TR?= NH3uU5RUSU6JRWK=
NCI-H1092 NEjhdXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2LwXWlEPTB;MU[uPFMyPiEQvF2= MWjTRW5ITVJ?
MZ2-MEL M3TBfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWnJR|UxRTF4Lki0NFMh|ryP MXTTRW5ITVJ?
ES3 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2fnb2lEPTB;MU[uPVE{PCEQvF2= MUnTRW5ITVJ?
COLO-684 M2TLbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnrRTWM2OD1zNj65OFc4KM7:TR?= NV36em5SW0GQR1XS
NCI-H661 M3HOSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn;oTWM2OD1zNj65Olk1KM7:TR?= M3\6bXNCVkeHUh?=
CP50-MEL-B MoX4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUnJR|UxRTF5LkCzOFMh|ryP NHTyRoFUSU6JRWK=
NCI-H2405 M2SzOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFjiSIRKSzVyPUG3MlE6PzRizszN Mlj0V2FPT0WU
U-2-OS MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3Xrb2lEPTB;MUeuOVMxPyEQvF2= MV\TRW5ITVJ?
RERF-LC-MS NIW2fY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkDaTWM2OD1zNz61OVA5KM7:TR?= MlP2V2FPT0WU
NCI-H2342 MlfCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFO1ZY5KSzVyPUG3MlU2PyEQvF2= MoXrV2FPT0WU
ES8 M{\yfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVe5UFV2UUN3ME2xO{43ODh5IN88US=> NILMbJpUSU6JRWK=
MOLT-16 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXXJcIZoUUN3ME2xO{45QTN2IN88US=> Mn\5V2FPT0WU
RH-18 MkLzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkSxTWM2OD1zOD6wNFM2KM7:TR?= NEf2T|ZUSU6JRWK=
D-283MED M2LMRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIDXcHBKSzVyPUG4MlAxQDhizszN M2f2XHNCVkeHUh?=
RCC10RGB MmnwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIDrd3RKSzVyPUG4MlA2PTlizszN M3jpb3NCVkeHUh?=
NCI-H1437 NUX6VYZKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFrmUGVKSzVyPUG4MlE3PDFizszN M{\wRXNCVkeHUh?=
SW982 MoryS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXy4XVZpUUN3ME2xPE4zPjdzIN88US=> MULTRW5ITVJ?
IST-MES1 Mn[xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYHJR|UxRTF6LkS0Nlgh|ryP NFvGPYxUSU6JRWK=
A704 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIO2VlJKSzVyPUG4MlQ4PTNizszN MY\TRW5ITVJ?
ESS-1 NFfRZlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGj3dpNKSzVyPUG4MlUzODVizszN NXLCN|dZW0GQR1XS
SCH M2n2c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUjvZpl4UUN3ME2xPE43PDV4IN88US=> MUXTRW5ITVJ?
COLO-320-HSR MoDDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1HySWlEPTB;MUiuO|Q3KM7:TR?= MWPTRW5ITVJ?
Mo-T M2nBUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIHKboJKSzVyPUG4MlgzODRizszN NWHPZnUyW0GQR1XS
Saos-2 M3vlVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX\JR|UxRTF7LkGxOlIh|ryP NYjKVmpbW0GQR1XS
SW684 Ml\2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIHoTpRKSzVyPUG5MlE{OjZizszN M3XJWXNCVkeHUh?=
KMOE-2 NX\MOIhxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWLJR|UxRTF7LkKyOFIh|ryP NU\LVZpIW0GQR1XS
MMAC-SF MlntS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4K0T2lEPTB;MUmuNlYxPyEQvF2= Mlr1V2FPT0WU
JAR M1LQVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mly0TWM2OD1zOT6yPVkh|ryP MVLTRW5ITVJ?
SK-MEL-28 NGH0VVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmXvTWM2OD1zOT6zN|Y{KM7:TR?= MVjTRW5ITVJ?
KNS-81-FD M4faNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYX0blJbUUN3ME2xPU42PDZ6IN88US=> MoPkV2FPT0WU
ES7 NUmwc|M4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MojYTWM2OD1zOT62NlkzKM7:TR?= MWDTRW5ITVJ?
AsPC-1 NFW0PWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3HG[2lEPTB;MUmuOlQ4OSEQvF2= M37WUHNCVkeHUh?=
NCI-H1155 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn3mTWM2OD1zOT63NlM5KM7:TR?= NXzJW5F[W0GQR1XS
KYSE-510 M4HSXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXHJR|UxRTF7Lki3OFgh|ryP M4PWR3NCVkeHUh?=
ES1 NV;1SVRLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnzQTWM2OD1zOT65NlE{KM7:TR?= MYnTRW5ITVJ?
PC-3 NH\6eWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXvHNY9{UUN3ME2xPU46PjB2IN88US=> NVTCNI9FW0GQR1XS
GCT M1v5bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NETLPG1KSzVyPUKwMlMxOjZizszN MVvTRW5ITVJ?
KARPAS-299 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYLJR|UxRTJyLkO0NlIh|ryP MVnTRW5ITVJ?
DOHH-2 Mk\QS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVrYOY9KUUN3ME2yNE42PDZ|IN88US=> NHXKZWhUSU6JRWK=
COLO-741 M2\TWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVTzSFNMUUN3ME2yNE43PiEQvF2= MnzoV2FPT0WU
NCI-H1395 NH3uN25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1nvZmlEPTB;MkCuOlY6PyEQvF2= M1vURXNCVkeHUh?=
HCC1187 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVfzZZBkUUN3ME2yNE43PzN2IN88US=> M4\GRnNCVkeHUh?=
Becker M{\4e2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2rVO2lEPTB;MkCuO|IxOSEQvF2= M1rLe3NCVkeHUh?=
LU-134-A NXXFUFBiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUTJR|UxRTJzLkGwNlYh|ryP M4HBeXNCVkeHUh?=
MKN45 NF\0R4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTJzLkG1OVEh|ryP NHGwZo5USU6JRWK=
LC-2-ad MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mk\STWM2OD1{MT6yO|I6KM7:TR?= MVfTRW5ITVJ?
EW-24 NUT2TXM2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWTJR|UxRTJzLkO5OFUh|ryP M4OyenNCVkeHUh?=
SK-N-AS MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUTuTIo2UUN3ME2yNU45Ojd4IN88US=> MYDTRW5ITVJ?
NCI-H2052 NFTYO3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXHMVpJZUUN3ME2yNU45QTZ|IN88US=> NGDOboFUSU6JRWK=
A4-Fuk MlnZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWPJSVgxUUN3ME2yNk4yPDF7IN88US=> M2L2[nNCVkeHUh?=
NB10 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4rISmlEPTB;MkKuNlM4OSEQvF2= NVLnTlNmW0GQR1XS
CHP-212 M1TwOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1XYeGlEPTB;MkKuN|IzOiEQvF2= Ml:2V2FPT0WU
KM12 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEHxbndKSzVyPUKyMlM2PiEQvF2= NUXxWoJzW0GQR1XS
JEG-3 M{W1fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVm3OphrUUN3ME2yNk4{PzhizszN NHrRU3NUSU6JRWK=
LN-405 NF3RT4NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlvMTWM2OD1{Mj61PVE{KM7:TR?= NXTqe2VRW0GQR1XS
HCT-15 Mm\OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXzJR|UxRTJ{Lke0OFEh|ryP NInWU3lUSU6JRWK=
MLMA Mlr5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mmm2TWM2OD1{Mj63OFch|ryP MUXTRW5ITVJ?
GI-1 NV;EPGt6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NE\lNFlKSzVyPUKyMlc3PThizszN MlfqV2FPT0WU
RT-112 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUT6SWFTUUN3ME2yNk45PjF4IN88US=> NFzrTWpUSU6JRWK=
MPP-89 MoqyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlvsTWM2OD1{Mj64OlYyKM7:TR?= M{HncXNCVkeHUh?=
A3-KAW NWfnSYszT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoXTTWM2OD1{Mz6xNFA{KM7:TR?= NIWxWIRUSU6JRWK=
KALS-1 M4\q[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGTvW25KSzVyPUKzMlE1OTRizszN NXfHPYptW0GQR1XS
SF126 NHzr[5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGnCVGRKSzVyPUKzMlY6OjRizszN NYHM[Y5NW0GQR1XS
SiHa MoLPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYTkVoJ5UUN3ME2yN{46OzJ5IN88US=> M4LEO3NCVkeHUh?=
MDA-MB-415 NWPybGd{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHPB[|RKSzVyPUKzMlk1QTlizszN MnHNV2FPT0WU
Daoy MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NG\qSHlKSzVyPUK0MlEzPiEQvF2= MWjTRW5ITVJ?
COR-L23 MnvQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2n0e2lEPTB;MkSuNVc3PyEQvF2= M3G1[XNCVkeHUh?=
KG-1 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MY\JR|UxRTJ2LkG5Nlgh|ryP MXjTRW5ITVJ?
L-428 NE\BTWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2fCeWlEPTB;MkSuOVc6OSEQvF2= MmG1V2FPT0WU
NCI-H520 M2fKd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFvk[ppKSzVyPUK0Mlg5PjFizszN MmTJV2FPT0WU
COLO-792 NG[5V2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4HlTmlEPTB;MkWuNlc{OiEQvF2= M4HCPXNCVkeHUh?=
NB12 NVrF[W9GT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXjJR|UxRTJ3LkK5OFch|ryP Mm\hV2FPT0WU
GAK NGXDTmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVzoemlnUUN3ME2yOU4zQTZ|IN88US=> Mof5V2FPT0WU
SW780 M4LhUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWnpc5dnUUN3ME2yOU4{OjZ2IN88US=> NF:2eWhUSU6JRWK=
GB-1 M1\UOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVu5XZJTUUN3ME2yOU41ODZ7IN88US=> MYnTRW5ITVJ?
P12-ICHIKAWA M{fQNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVHFblc4UUN3ME2yOU41Pzh3IN88US=> NF7qb|NUSU6JRWK=
NCI-H1651 M4P5Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4[zWWlEPTB;MkWuOVk4KM7:TR?= MWTTRW5ITVJ?
KE-37 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3nv[mlEPTB;MkWuO|MyPSEQvF2= NVL6RYprW0GQR1XS
CCRF-CEM MmCyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVLmU3ZHUUN3ME2yOU46PjdizszN NV21VIgzW0GQR1XS
SF295 MljzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkjGTWM2OD1{Nj6wOFI2KM7:TR?= NELr[XVUSU6JRWK=
G-361 NInxcFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGLUbFdKSzVyPUK2MlExOjdizszN MUHTRW5ITVJ?
HOP-92 NEL3OGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWnJR|UxRTJ4LkGyNlYh|ryP MUHTRW5ITVJ?
UMC-11 MmfhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnWwTWM2OD1{Nj60OVE1KM7:TR?= MoP6V2FPT0WU
IST-SL1 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX20OVdlUUN3ME2yOk43PTlzIN88US=> M2m0eXNCVkeHUh?=
TE-11 MorOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NW\kdZpzUUN3ME2yOk44PzV{IN88US=> M1:2[nNCVkeHUh?=
NCI-H1304 NEPHN|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVLJR|UxRTJ4LkmxNFgh|ryP NHTneYZUSU6JRWK=
SJSA-1 M3fwSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlHWTWM2OD1{Nz6wNVc3KM7:TR?= MXjTRW5ITVJ?
BCPAP MkLKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXPJR|UxRTJ5LkGzO{DPxE1? NHG5UlJUSU6JRWK=
HTC-C3 M4rUemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M33EcGlEPTB;MkeuNlU3OSEQvF2= NWTXWFdKW0GQR1XS
EW-16 NXLWcphxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUPIdGViUUN3ME2yO{4zQTR5IN88US=> MUPTRW5ITVJ?
HT-144 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXrJR|UxRTJ5LkSwN|Ih|ryP NHvC[JBUSU6JRWK=
MHH-ES-1 NIT1XoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NILEcHJKSzVyPUK3MlQ1PDdizszN NHz4O2ZUSU6JRWK=
T98G NXzufZNRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1uwXWlEPTB;MkeuOVg1PiEQvF2= MnPWV2FPT0WU
RPMI-8866 NVLyWZBzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYPJR|UxRTJ5Lke1OlIh|ryP MmnnV2FPT0WU
BEN MoToS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn3JTWM2OD1{Nz64OVE4KM7:TR?= MXvTRW5ITVJ?
MDA-MB-231 M37ZVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGTpN4JKSzVyPUK4MlI4QTVizszN MkXXV2FPT0WU
HuH-7 M130OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVzre|ZMUUN3ME2yPE41ODJ6IN88US=> M{O4T3NCVkeHUh?=
SK-N-FI MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWDJR|UxRTJ6LkSzN{DPxE1? NInTUIJUSU6JRWK=
AN3-CA NIrrZnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVjJR|UxRTJ6LkSzPVUh|ryP NVzFO4ppW0GQR1XS
EGI-1 M3PEbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYfJR|UxRTJ6LkW5Nlgh|ryP NGflToRUSU6JRWK=
697 Moq5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFjacmdKSzVyPUK4MlY{OzFizszN NHnPTWRUSU6JRWK=
TCCSUP NWjKfYxLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{TSZmlEPTB;MkiuOlQyQCEQvF2= MVXTRW5ITVJ?
GR-ST MnTCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYHJR|UxRTJ6Lk[2PVYh|ryP MlHIV2FPT0WU
SK-N-DZ MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3;3RWlEPTB;MkiuOlg5PSEQvF2= NYLEXG1UW0GQR1XS
MIA-PaCa-2 NIH3TVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVrJR|UxRTJ6Lke5OVkh|ryP M4nNbXNCVkeHUh?=
IGR-1 MoDNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MojBTWM2OD1{OD64PFc1KM7:TR?= NHHtN2pUSU6JRWK=
BFTC-905 NXjLVHZyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MW\JR|UxRTJ7LkK3NFUh|ryP M1rOdnNCVkeHUh?=
NCI-H1581 NUTaOGx1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4[xSmlEPTB;MkmuN|E1PSEQvF2= NVHybWZGW0GQR1XS
RD M4LXbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3njXGlEPTB;MkmuOVI{OyEQvF2= NVrMWWY5W0GQR1XS
SF268 MoDrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVfkbpF6UUN3ME2yPU42QTNzIN88US=> MXnTRW5ITVJ?
SHP-77 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUK1d3duUUN3ME2yPU43OTh{IN88US=> MUnTRW5ITVJ?
D-566MG NXv5VW1QT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmTrTWM2OD1{OT65N|k{KM7:TR?= NX;yNGptW0GQR1XS
TGBC1TKB MkLvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MknXTWM2OD1|MD6xNlM5KM7:TR?= Mn61V2FPT0WU
MEL-HO MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF[2S4RKSzVyPUOwMlE1OjNizszN M2rHUHNCVkeHUh?=
SJRH30 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mnm5TWM2OD1|MD6yNVA5KM7:TR?= NGXWcJhUSU6JRWK=
D-336MG M2Lzcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MorBTWM2OD1|MD6yPFkzKM7:TR?= MX3TRW5ITVJ?
C3A NXjzRoQxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{KzeGlEPTB;M{CuNlkzPyEQvF2= MnLHV2FPT0WU
Calu-6 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGHEOZNKSzVyPUOwMlI6PjNizszN NF3Ec|VUSU6JRWK=
MZ1-PC M3[z[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHHBfXVKSzVyPUOwMlM6OyEQvF2= MULTRW5ITVJ?
KYSE-70 NUXRZVhQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mkm1TWM2OD1|MD61NVE1KM7:TR?= NYTJRZRyW0GQR1XS
CAPAN-1 M{LN[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MljUTWM2OD1|MD61NVgyKM7:TR?= NULMNol6W0GQR1XS
DK-MG MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVzJR|UxRTNyLkW0OVYh|ryP NXvFdXN6W0GQR1XS
SK-HEP-1 MljpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1jqemlEPTB;M{CuOlMzPiEQvF2= NGLPVoNUSU6JRWK=
MS-1 M1PrVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWTJR|UxRTNyLki4PFkh|ryP NFzGdJNUSU6JRWK=
GI-ME-N MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnnFTWM2OD1|MT6wOVcyKM7:TR?= M1H3[XNCVkeHUh?=
NCI-H510A NXryTlZ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXfJR|UxRTNzLkSwNFYh|ryP MmTQV2FPT0WU
NB17 M1ntXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYXJR|UxRTNzLkWxPFUh|ryP NGTNelFUSU6JRWK=
639-V NXPSb3RZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2LoUGlEPTB;M{GuOVI1OyEQvF2= Mm\OV2FPT0WU
CAL-51 NET3RYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn[3TWM2OD1|MT61OlY4KM7:TR?= MorkV2FPT0WU
HGC-27 NHj4WG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVPL[3hIUUN3ME2zNU42QDd|IN88US=> NXTSWnNoW0GQR1XS
GOTO NX\KdIhuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3jnZWlEPTB;M{GuPFUxPiEQvF2= Mn;IV2FPT0WU
ChaGo-K-1 Mo\xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NI\0eG5KSzVyPUOyMlAxPyEQvF2= M{m3eXNCVkeHUh?=
RO82-W-1 M3r3[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXXJR|UxRTN{LkG2NFQh|ryP NVnGd|dDW0GQR1XS
SH-4 NXjWV2tYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2fpSGlEPTB;M{KuNVg2QCEQvF2= MkKzV2FPT0WU
A204 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHqyXIRKSzVyPUOyMlUxPjlizszN MlXCV2FPT0WU
DMS-273 NXLwTopQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGPu[|BKSzVyPUOyMlU{OjJizszN M1na[HNCVkeHUh?=
KGN MmnYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWLIUJJkUUN3ME2zNk43OzNizszN MUPTRW5ITVJ?
SK-MEL-2 MkLLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4Pm[GlEPTB;M{KuOlUzPyEQvF2= M13BeHNCVkeHUh?=
NCI-H2228 NYDLeJF1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXPJR|UxRTN{Lk[2NFIh|ryP Mn3OV2FPT0WU
MKN28 MoHwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3HkcmlEPTB;M{KuO|g{QCEQvF2= MYDTRW5ITVJ?
H-EMC-SS NYrmU3BxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH3ISm9KSzVyPUOyMlk3PzhizszN NIDXN|FUSU6JRWK=
ATN-1 MlqxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWPJR|UxRTN|LkG0NVYh|ryP MWHTRW5ITVJ?
D-263MG MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX7lRm17UUN3ME2zN{45Ozd6IN88US=> NYrrR3JoW0GQR1XS
LU-135 NYH5NXNlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGmwSoVKSzVyPUOzMlg5OjlizszN NYHkXXBOW0GQR1XS
C8166 NXvvZ45WT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXvCcGMzUUN3ME2zN{45QDV2IN88US=> M3f6eXNCVkeHUh?=
T-24 MnmwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVHJR|UxRTN2LkCyNFUh|ryP NWjnUoNFW0GQR1XS
Mewo NYPKVlRLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWLrNYhZUUN3ME2zOE4yOzR7IN88US=> MlyyV2FPT0WU
22RV1 NX;CWZRFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NELLUIJKSzVyPUO0MlE4PTRizszN MoDaV2FPT0WU
KM-H2 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3frSGlEPTB;M{SuNVc4QSEQvF2= MnTXV2FPT0WU
NCI-H2122 MoXpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXvJR|UxRTN2LkO0O|Eh|ryP Mme4V2FPT0WU
ABC-1 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXvkco5ZUUN3ME2zOE4{Pjl|IN88US=> MVrTRW5ITVJ?
NCI-H1355 NEDGeWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWHJR|UxRTN2LkO4PFkh|ryP M4\IcXNCVkeHUh?=
NOMO-1 M3jBXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVrVXlN6UUN3ME2zOE42PzB|IN88US=> MULTRW5ITVJ?
MZ7-mel M1S0cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVzJR|UxRTN2Lk[0PFch|ryP M3vRc3NCVkeHUh?=
NCI-H810 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWrJR|UxRTN2LkeyO|gh|ryP MlnDV2FPT0WU
D-392MG NYDiPHc6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYPkfppTUUN3ME2zOU4xPTZ3IN88US=> NGrWSG1USU6JRWK=
LB771-HNC NH3pd4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWfJR|UxRTN3LkG2OVgh|ryP NVj0dJBoW0GQR1XS
COLO-679 MmKwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVvJR|UxRTN3LkO4PEDPxE1? M{TlXHNCVkeHUh?=
SK-PN-DW Mo\IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVjJR|UxRTN3LkSzOlkh|ryP NW\5b2JoW0GQR1XS
VA-ES-BJ MkDQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1TBZ2lEPTB;M{WuOFY1QSEQvF2= NIfxOlRUSU6JRWK=
KNS-42 NVLYeZFMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVvJR|UxRTN3LkW4NlYh|ryP MWrTRW5ITVJ?
RVH-421 MoS4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUPi[XFpUUN3ME2zOU44PjR3IN88US=> MlzrV2FPT0WU
P30-OHK MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWrJR|UxRTN3Lki3OVIh|ryP NUiyZoExW0GQR1XS
G-402 NIPl[IJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVvCcGw2UUN3ME2zOU46QDZ5IN88US=> MnTqV2FPT0WU
S-117 M2ruT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHvwSIdKSzVyPUO2MlMxODhizszN Mlr5V2FPT0WU
RXF393 NYTVe3pvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1j0bGlEPTB;M{[uN|c5PSEQvF2= MVHTRW5ITVJ?
LCLC-103H Ml\JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFHaeHBKSzVyPUO2Mlc5ODNizszN M2rtXnNCVkeHUh?=
U-118-MG M{P2d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{HOSGlEPTB;M{[uPFg1PyEQvF2= M162W3NCVkeHUh?=
8-MG-BA MkDLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoTZTWM2OD1|Nj65OFg{KM7:TR?= MWXTRW5ITVJ?
MFH-ino MlvnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUK2[Gw5UUN3ME2zO{4{OzdzIN88US=> NX7QNoE{W0GQR1XS
NCI-H23 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2rJUGlEPTB;M{euOFE6PiEQvF2= NInxfFFUSU6JRWK=
NCI-H446 Mn[wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUDJR|UxRTN5LkS4OlIh|ryP MVfTRW5ITVJ?
LU-99A NXXCTJpKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYLJR|UxRTN5LkW3N|Eh|ryP NIKzTVdUSU6JRWK=
KP-N-YN NXf2U49GT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIruRZpKSzVyPUO3MlYyQTVizszN MnnQV2FPT0WU
SCC-9 NX7KT25GT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUTJR|UxRTN5Lke4N|gh|ryP NUD6WGV4W0GQR1XS
EFM-19 NHXQR4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3O3NWlEPTB;M{euO|k3PyEQvF2= Ml7xV2FPT0WU
A427 NFzqeWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWLJR|UxRTN5LkmxNFch|ryP NHLrS2NUSU6JRWK=
LB831-BLC NYjzVm9uT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVjZU5NLUUN3ME2zPE43ODN7IN88US=> M4LrfnNCVkeHUh?=
HOS MmX4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoGxTWM2OD1|OT62Nlc{KM7:TR?= M{WwVHNCVkeHUh?=
LAN-6 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1PERmlEPTB;NECuNFEyOiEQvF2= NEn0TFlUSU6JRWK=
U251 NWfuO4Y3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHq4doVKSzVyPUSwMlQxPTRizszN MXHTRW5ITVJ?
SNU-387 M1fyOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NU\M[mdnUUN3ME20NE41PTV|IN88US=> Ml3qV2FPT0WU
DMS-79 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1nkUGlEPTB;NECuOVg5QSEQvF2= NWf6eIdoW0GQR1XS
SK-LU-1 NHPFS|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYHJR|UxRTRyLk[1Olgh|ryP MXTTRW5ITVJ?
HT NIfFO2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml7DTWM2OD12MD62OlM6KM7:TR?= NWKyW|ExW0GQR1XS
KP-N-YS M3Oyb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFT6NHpKSzVyPUSwMlY4PjhizszN NFy3WZZUSU6JRWK=
DMS-114 MmLRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2\mT2lEPTB;NECuPFM4PCEQvF2= M{Lld3NCVkeHUh?=
HUTU-80 NUHTN4VQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1XxV2lEPTB;NEGuNFU3QSEQvF2= NGDQTmVUSU6JRWK=
ONS-76 NX;5[GY6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFS2SmdKSzVyPUSxMlQ4ODlizszN NHjzbJJUSU6JRWK=
A673 NXjwXZRST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUPGV2RPUUN3ME20NU42OTV5IN88US=> M33OVnNCVkeHUh?=
HPAF-II MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2joWWlEPTB;NEGuOlcxQSEQvF2= NXXxd2F{W0GQR1XS
UACC-257 NYTZbJNMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnjBTWM2OD12MT63N|Y6KM7:TR?= M3OzR3NCVkeHUh?=
EW-22 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXvXOIdtUUN3ME20NU45Pjl5IN88US=> M4\EOXNCVkeHUh?=
NCI-H1755 M2K0bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NELTNYNKSzVyPUSxMlg4OjVizszN MkHXV2FPT0WU
KYSE-150 NHfUNZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn7ETWM2OD12Mj6xO|gzKM7:TR?= NUDBO29mW0GQR1XS
CGTH-W-1 MoDMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF7ne4JKSzVyPUSyMlQ6PTVizszN MnLtV2FPT0WU
NB13 NGPsc4NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX3JR|UxRTR{Lk[yNVch|ryP NGXOb3ZUSU6JRWK=
SW872 NGnjTIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{fOd2lEPTB;NEKuOlM{OSEQvF2= NFrrPWpUSU6JRWK=
KP-4 M4rKTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkXLTWM2OD12Mj64PFMzKM7:TR?= NGTIN2VUSU6JRWK=
HCC38 MmLaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NETEeGVKSzVyPUSyMlk3OThizszN MV7TRW5ITVJ?
BB49-HNC NFnOWnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGK2eI9KSzVyPUSzMlI{PTZizszN NGLNWnhUSU6JRWK=
CAL-62 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoPoTWM2OD12Mz60NFI5KM7:TR?= NFXUelBUSU6JRWK=
NCI-H2029 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFO5WlRKSzVyPUSzMlU2QDFizszN NV7hWlhHW0GQR1XS
M14 NF:zc3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFXMNIdKSzVyPUS0MlE{OzJizszN NGDnN4FUSU6JRWK=
COLO-680N MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH;XZXFKSzVyPUS0MlM{QSEQvF2= MXLTRW5ITVJ?
Hs-578-T M4O2OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml64TWM2OD12NT6wNlk1KM7:TR?= NETs[4lUSU6JRWK=
MSTO-211H Mlz6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmfNTWM2OD12NT65OFgzKM7:TR?= MVjTRW5ITVJ?
EW-1 M1WzZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHnLc3BKSzVyPUS1Mlk3QDlizszN M1nlPHNCVkeHUh?=
SW948 M{\0dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUnJR|UxRTR4LkS0OlIh|ryP NUfieY44W0GQR1XS
NCI-H460 NYXFWVRpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1O3b2lEPTB;NE[uOVI{KM7:TR?= NWqzeIJ4W0GQR1XS
CAS-1 Mnr0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXXJR|UxRTR4Lke3NFEh|ryP M1\nOnNCVkeHUh?=
TGBC11TKB NYPK[It4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn7KTWM2OD12Nz6xO|c4KM7:TR?= M3zodHNCVkeHUh?=
HD-MY-Z NY\HOJdKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYniW4NWUUN3ME20PE44QDZizszN NIP5Nm5USU6JRWK=
NCI-H226 Mn63S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV3FOZRFUUN3ME20PU44Pzh3IN88US=> M17iWHNCVkeHUh?=
PA-1 M3:4VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYrJR|UxRTR7LkizN|Uh|ryP MojWV2FPT0WU
LB2518-MEL NGDPSpRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnL4TWM2OD12OT64O|I{KM7:TR?= NYjvR4NoW0GQR1XS
A101D MmnNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml;KTWM2OD12OT65OFI2KM7:TR?= MVzTRW5ITVJ?
NCI-H2087 NFeySnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1HVO2lEPTB;NEmuPVY5OiEQvF2= M1TU[XNCVkeHUh?=

... Click to View More Cell Line Experimental Data

In vivo Daily oral administration of BIBW2992 at 20 mg/kg for 25 days results in dramatic tumor regression with a cumulative treated/control tumor volume ratio (T/C ratio) of 2%. Reduced phosphorylation of EGFR and AKT is confirmed by immunohistochemical staining of tissue sections. Therefore, like lapatinib and neratinib, BIBW2992 is a next generation tyrosine kinase inhibitor (TKI) that inhibits human epidermal growth factor receptor 2 (Her2) and epidermal growth factor receptor (EGFR) kinases irreversibly. BIBW2992 is not only active against EGFR mutations targeted by first generation TKIs like Erlotinib or Gefitinib, but also against those insensitive to these standard therapies. [1]

Protocol

Kinase Assay:

[1]

+ Expand

In vitro kinase activity assays:

The wild type tyrosine kinase domain of the human EGFR as well as that of the EGFR L858R/T790M double mutant are fused to Glutathione-S-transferase (GST), and extracted. Enzyme activity is then assayed in the presence of the inhibitor BIBW2992, serially diluted in 50% DMSO. A random polymer pEY (4:1) is used as substrate and biotinylated pEY (bio-pEY) is added as a tracer substrate. The kinase domain of HER2 is cloned using the baculovirus system and extracted similarly to that of EGFR kinase. Details of assays for EGFR, HER2, SRC, BIRK and VEGFR2 kinase activity are available in Supplementary information.
Cell Research:

[1]

+ Expand
  • Cell lines: NSCLC cells
  • Concentrations: 0-10 μM
  • Incubation Time: 1 hour
  • Method:

    1 × 104 NSCLC cells are transferred into each well of a 96-well plate and cultured overnight in serum-free media for the EGFR phosphorylation assay. After addition of BIBW2992 on the next day, the plates are incubated at 37 °C for 1 hour. EGF-stimulation is done using 100 ng/mL for 10 min at room temperature. Cells are washed with ice cold PBS, extracted with 120 μL HEPEX buffer per well and shaken at room temperature for 1 hour. In all 2 × 104 cells per well is used for the HER2 phosphorylation assay. Streptavidin precoated plates are coated with anti-EGFR-biotin at 1:100 dilution in blocking buffer and c-erb2/HER2 oncoprotein Ab-5(Clone N24)-Biotin. Cell extracts is then transferred to the antibody-coated wells and incubated at room temperature for 1 hour. Extinction is measured at 450 nm.


    (Only for Reference)
Animal Research:

[1]

+ Expand
  • Animal Models: Athymic NMRI-nu/nu female mice
  • Formulation: In 0.5% methocellulose-0.4% polysorbate-80 (Tween 80)
  • Dosages: 20 mg/kg
  • Administration: Oral administration
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 97 mg/mL (199.61 mM)
Ethanol 15 mg/mL (30.86 mM)
Water Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
2% DMSO+30% PEG 300+5% Tween 80+ddH2O
For best results, use promptly after mixing.
10mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 485.94
Formula

C24H25ClFN5O3

CAS No. 439081-18-2
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02780687 Recruiting Urologic Neoplasms Boehringer Ingelheim June 9 2016 Phase 2
NCT02131259 Completed Carcinoma Non-Small-Cell Lung Boehringer Ingelheim May 7 2014 --
NCT02216617 Completed HNSCC Groupe Oncologie Radiotherapie Tete et Cou August 6 2014 Phase 1
NCT02451553 Recruiting Advanced Malignant Solid Neoplasm|Bile Duct Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IVA Pancreatic Cancer|Stage IVB Pancreatic Cancer University of Washington|National Cancer Institute (NCI) November 5 2015 Phase 1
NCT01523587 Completed Carcinoma Non-Small-Cell Lung Boehringer Ingelheim March 5 2012 Phase 3
NCT01345682 Completed Head and Neck Neoplasms|Carcinoma Squamous Cell Boehringer Ingelheim January 5 2012 Phase 3

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    What’s the recommendation about reconstitution of the compound for in vivo animal study?

  • Answer:

    For in vivo experiment of afatinib, we recommend 0.5% methylcellulose/0.2% Tween 80 as vehicle.

EGFR Signaling Pathway Map

EGFR Inhibitors with Unique Features

Related EGFR Products4

Tags: buy Afatinib (BIBW2992) | Afatinib (BIBW2992) supplier | purchase Afatinib (BIBW2992) | Afatinib (BIBW2992) cost | Afatinib (BIBW2992) manufacturer | order Afatinib (BIBW2992) | Afatinib (BIBW2992) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID